OSR Health (OSRHW) Assets Average (2023 - 2026)
OSR Health (OSRHW) posted Assets Average of $171.7 million for Q1 2026, down 1.46% sequentially from $174.3 million in Q4 2025, and down 1.82% YoY from $174.9 million in Q1 2025.
OSR Health (OSRHW) Assets Average (2023 - 2026) Analysis & Trends
OSR Health has reported Assets Average for 4 years, with the latest figure at $171.7 million in Q1 2026.
- Quarterly Assets Average fell 1.82% year-over-year to $171.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $171.7 million (down 1.82% YoY) and the FY2025 annual result came in at $173.2 million, up 63.54% from the prior year.
- Assets Average declined to $171.7 million in Q1 2026 per OSRHW's latest filing, from $174.3 million in the prior quarter.
- Over five years, Assets Average peaked at $181.4 million in Q3 2025 and troughed at $20.8 million in Q3 2024.
- A 4-year average of $100.0 million and a median of $71.8 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average plunged 71.07% in 2024, then jumped 772.74% in 2025.
- Over 4 years, Assets Average stood at $54.4 million in 2023, then surged by 80.36% to $98.1 million in 2024, then jumped by 77.67% to $174.3 million in 2025, then dropped by 1.46% to $171.7 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $171.7 million, $174.3 million, and $181.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 19.82 Bn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 2.09 Bn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 169.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.71 Mn |
| Dec 31, 2025 | 174.26 Mn |
| Sep 30, 2025 | 181.35 Mn |
| Jun 30, 2025 | 179.98 Mn |
| Mar 31, 2025 | 174.89 Mn |
| Dec 31, 2024 | 98.08 Mn |
| Sep 30, 2024 | 20.78 Mn |
| Jun 30, 2024 | 28.95 Mn |
| Mar 31, 2024 | 36.95 Mn |
| Dec 31, 2023 | 54.38 Mn |
| Sep 30, 2023 | 71.82 Mn |
| Jun 30, 2023 | 71.27 Mn |
| Mar 31, 2023 | 36.14 Mn |